Piero Marone

Medicine & Life Sciences

1. Italy 100%
2. Infections 67%
3. Klebsiella pneumoniae 49%
4. Colistin 46%
5. Anti-Bacterial Agents 35%
6. Intensive Care Units 34%
7. Mycobacterium tuberculosis 33%
8. Genome 31%
9. Carbapenems 31%
10. Bacteremia 31%
11. Disease Outbreaks 29%
12. Staphylococcus 29%
13. Blood Culture 28%
14. Tuberculosis 25%
15. Transplant Recipients 24%
16. Methicillin-Resistant Staphylococcus aureus 21%
17. Teicoplanin 20%
18. Genes 19%
19. Rifampin 19%
20. Yeasts 19%
21. Escherichia coli Infections 19%
22. Candida 18%
23. Streptococcus agalactiae 18%
24. Epidemiology 18%
25. Staphylococcus epidermidis 18%
26. Mycobacterium avium Complex 18%
27. Amikacin 17%
28. Lung 17%
29. HIV 17%
30. CD4 Lymphocyte Count 16%
31. Opportunistic Infections 16%
32. In Vitro Techniques 16%
33. Catheters 16%
34. Polymerase Chain Reaction 16%
35. Enterobacteriaceae 16%
36. Lyme Neuroborreliosis 16%
37. Therapeutics 15%
38. Endocarditis 15%
39. Aminoglycosides 15%
40. Pharmaceutical Preparations 15%
41. Drug Resistance 15%
42. Ciprofloxacin 14%
43. Cat-Scratch Disease 14%
44. SARS Virus 14%
45. Fungi 14%
46. Silver Sulfadiazine 14%
47. Klebsiella 14%
48. Escherichia coli 13%
49. Sepsis 13%
50. Mycobacterium 13%